Ironwood Pharmaceuticals Inc (NASDAQ: IRWD) is -61.10% lower on its value in year-to-date trading and has touched a low of $3.06 and a high of $15.70 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The IRWD stock was last observed hovering at around $3.88 in the last trading session, with the day’s gains setting it 0.57%.
Currently trading at $4.45, the stock is 23.22% and 11.69% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 11.01 million and changing 14.69% at the moment leaves the stock -22.87% off its SMA200. IRWD registered -59.55% loss for a year compared to 6-month loss of -29.59%. The firm has a 50-day simple moving average (SMA 50) of $3.9844 and a 200-day simple moving average (SMA200) of $5.76915.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The stock witnessed a 26.42% gain in the last 1 month and extending the period to 3 months gives it a 9.07%, and is 26.06% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 15.07% over the week and 10.53% over the month.
Ironwood Pharmaceuticals Inc (IRWD) has around 267 employees, a market worth around $816.75M and $378.42M in sales. Fwd P/E is 17.52. Profit margin for the company is -0.65%. Distance from 52-week low is 45.42% and -71.66% from its 52-week high. The company has generated returns on investments over the last 12 months (-0.82%).
with sales reaching $92.5M over the same period.The EPS is expected to grow by 101.55% this year, but quarterly earnings will post -20.17% year-over-year. Quarterly sales are estimated to shrink -21.31% in year-over-year returns.
Ironwood Pharmaceuticals Inc (IRWD) Top Institutional Holders
318.0 institutions hold shares in Ironwood Pharmaceuticals Inc (IRWD), with institutional investors hold 107.08% of the company’s shares. The shares outstanding are 160.02M, and float is at 155.78M with Short Float at 7.20%. Institutions hold 105.29% of the Float.
The top institutional shareholder in the company is BLACKROCK INC. with over 22.88 million shares valued at $149.16 million. The investor’s holdings represent 14.5067% of the IRWD Shares outstanding. As of 2024-06-30, the second largest holder is VANGUARD GROUP INC with 21.56 million shares valued at $140.59 million to account for 13.6737 of the shares outstanding. The other top investors are SARISSA CAPITAL MANAGEMENT LP which holds 16.39 million shares representing 10.3932% and valued at over $106.86 million, while UBS GROUP AG holds 7.1023 of the shares totaling 11.2 million with a market value of $73.03 million.
Ironwood Pharmaceuticals Inc (IRWD) Insider Activity
The most recent transaction is an insider sale by Davis Andrew, the company’s SVP, Chief Business Officer. SEC filings show that Davis Andrew sold 5,360 shares of the company’s common stock on Nov 18 ’24 at a price of $4.08 per share for a total of $21869.0. Following the sale, the insider now owns 0.28 million shares.
Ironwood Pharmaceuticals Inc disclosed in a document filed with the SEC on Nov 18 ’24 that Emany Sravan Kumar (SVP, COO and CFO) sold a total of 11,001 shares of the company’s common stock. The trade occurred on Nov 18 ’24 and was made at $4.08 per share for $44884.0. Following the transaction, the insider now directly holds 0.31 million shares of the IRWD stock.
Still, SEC filings show that on Nov 18 ’24, Davis Andrew (Officer) Proposed Sale 6,090 shares at an average price of $4.11 for $25030.0. The insider now directly holds shares of Ironwood Pharmaceuticals Inc (IRWD).
